Xontogeny
Boston, Massachusettsxontogeny.com
Overview
Xontogeny is a life sciences accelerator and investment firm that provides seed capital, strategic guidance, and operational support to early-stage companies developing therapeutics, diagnostics, and medical devices.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| CereVasc | May 2024 | Series B | Co-investor |
| TORL BioTherapeutics | Apr 2024 | Series B Extension | - |
| Neurosterix | Apr 2024 | Series A | Lead |
| Avalyn Pharma | Sep 2023 | Series C | Lead |
| TORL BioTherapeutics | Apr 2023 | Series B | Co-investor |
Key People
Fred Callori
Senior Partner
Gianna Hoffman-Luca
Partner
Heather Antioquia
Vice President, Program Development
Takeru Furuya
Principal Entrepreneur-in-Residence
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
